Literature DB >> 8157624

Oncostatin M binds directly to gp130 and behaves as interleukin-6 antagonist on a cell line expressing gp130 but lacking functional oncostatin M receptors.

E Sporeno1, G Paonessa, A L Salvati, R Graziani, P Delmastro, G Ciliberto, C Toniatti.   

Abstract

Oncostatin M (OM) and interleukin 6 (IL-6) are functionally related cytokines, which trigger similar biological responses because they share gp130 as a common signal transducing transmembrane receptor. While IL-6 recruits gp130 only upon binding to its specific receptor subunit (IL-6R alpha), reconstitution and cross-linking experiments on cell membranes suggest that OM can directly interact with gp130 and that this interaction is necessary but not sufficient to stimulate cells. However, the issue of the direct binding between gp130 and OM, in the absence of any additional membrane component, remained essentially unclarified. In this paper we show that, uniquely among the family of cytokines that transduce through gp130, OM directly binds in vitro with a 10(-8) M affinity sgp130, a soluble form of gp130. Moreover, titration of sgp130 with OM inhibits the formation of a ternary complex comprising IL-6, sIL-6R alpha, and sgp130. These in vitro properties of OM are consistent with the additional finding that on human hepatoma Hep3B cells, which express gp130 but not functional OM receptors, OM does not mimic IL-6 activity, but rather behaves, at high doses, as an IL-6 antagonist.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8157624

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Definition and characterization of an inhibitor for interleukin-31.

Authors:  Emilie Venereau; Caroline Diveu; Linda Grimaud; Elisa Ravon; Josy Froger; Laurence Preisser; Yannic Danger; Mike Maillasson; Laure Garrigue-Antar; Yannick Jacques; Sylvie Chevalier; Hugues Gascan
Journal:  J Biol Chem       Date:  2010-03-24       Impact factor: 5.157

2.  Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity.

Authors:  C Toniatti; A Cabibbo; E Sporena; A L Salvati; M Cerretani; S Serafini; A Lahm; R Cortese; G Ciliberto
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

Review 3.  Interleukin-6: structure-function relationships.

Authors:  R J Simpson; A Hammacher; D K Smith; J M Matthews; L D Ward
Journal:  Protein Sci       Date:  1997-05       Impact factor: 6.725

4.  A unique loop structure in oncostatin M determines binding affinity toward oncostatin M receptor and leukemia inhibitory factor receptor.

Authors:  Srinivas Chollangi; Timothy Mather; Karla K Rodgers; John D Ash
Journal:  J Biol Chem       Date:  2012-07-24       Impact factor: 5.157

5.  Resonance assignments for Oncostatin M, a 24-kDa alpha-helical protein.

Authors:  R C Hoffman; F J Moy; V Price; J Richardson; D Kaubisch; E A Frieden; J D Krakover; B J Castner; J King; C J March; R Powers
Journal:  J Biomol NMR       Date:  1996-06       Impact factor: 2.835

6.  Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor.

Authors:  N J Van Wagoner; J W Oh; P Repovic; E N Benveniste
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

7.  One-step purification of recombinant proteins with the 6xHis tag and Ni-NTA resin.

Authors:  J Crowe; B S Masone; J Ribbe
Journal:  Mol Biotechnol       Date:  1995-12       Impact factor: 2.695

8.  High circulating levels of biologically inactive IL-6/SIL-6 receptor complexes in systemic juvenile idiopathic arthritis: evidence for serum factors interfering with the binding to gp130.

Authors:  P Pignatti; L Ciapponi; P Galle; M B Hansen; M Massa; C Meazza; G Paonessa; D Novick; G Ciliberto; A Martini; F De Benedetti
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

9.  Developmental abnormalities in mice transgenic for bovine oncostatin M.

Authors:  N Malik; H S Haugen; B Modrell; M Shoyab; C H Clegg
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

10.  Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling.

Authors:  G Paonessa; R Graziani; A De Serio; R Savino; L Ciapponi; A Lahm; A L Salvati; C Toniatti; G Ciliberto
Journal:  EMBO J       Date:  1995-05-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.